1 week AbbVie Falls 8% in 3 Months: Buy, Hold or Sell the Stock? Zacks
Investors who own ABBV stock may stay invested as the company has faced its biggest challenge quite well and looks set to return to robust growth next year.
AbbVie (ABBV) · Biotech · Politics · U.S.
X